The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes
Open accessAbstract
The ability of three quinolones, two beta-lactams, and one aminoglycoside to select resistant mutants was examined in tests with 30 isolates of commonly encountered nosocomial pathogens. Ciprofloxacin and norfloxacin, two new quinolone derivatives, were no more likely to select resistant mutants than amikacin, whereas nalidixic acid, an older quinolone derivative, was the most likely of the six drugs examined to select resistant mutants. Mutational frequencies of 10(-7) to 10(-8) were observed in most instances. In general, the mutants were 8 to 16 times less susceptible to the drug used for selection. Although most quinolone-selected mutants were cross-resistant only to other drugs within this class, certain mutants of Klebsiella pneumoniae selected by nalidixic acid, ciprofloxacin, or norfloxacin were also less susceptible to beta-lactam antibiotics. This unusual pattern of multiple drug resistance was associated with changes in outer membrane proteins of the organism. Multiple drug resistance was also observed in beta-lactam-selected mutants of Enterobacter cloacae and Pseudomonas aeruginosa (beta-lactams), amikacin-selected mutants of Providencia stuartii and P. aeruginosa (aminoglycosides), and beta-lactam- or amikacin-selected mutants of Serratia marcescens (beta-lactams plus aminoglycosides). These results underscore the need to examine carefully the frequency with which resistance to any new antibiotic develops, as well as the patterns of multiple drug resistance which may occur simultaneously.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic Susceptibility Testing by a Standardized Single Disk Method
Bauer, A. W., Kirby, W. M. M., Sherris, J. C., & Turck, M. (1966) · American Journal of Clinical Pathology · doi:10.1093/ajcp/45.4_ts.493 · Cited by 18,523
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Lugtenberg, B., Meijers, J., Peters, R., van der Hoek, P., & van Alphen, L. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)80272-9 · Cited by 1,416
An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.
Steers, E., Foltz, E. L., & GRAVES, B. S. (1959) · PubMed · Cited by 1,063
Resolution of Bacterial Proteins by Polyacrylamide Gel Electrophoresis on Slabs
Ames, G. F.-L. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43074-3 · Cited by 753
DNA Gyrase and the Supercoiling of DNA
Cozzarelli, N. R. (1980) · Science · doi:10.1126/science.6243420 · Cited by 711
Porin channels in Escherichia coli: studies with beta-lactams in intact cells
Nikaido, H., Rosenberg, E. Y., & Foulds, J. (1983) · Journal of Bacteriology · doi:10.1128/jb.153.1.232-240.1983 · Cited by 379
George, A. M., & Levy, S. B. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.531-540.1983 · Cited by 352
Proteins of the Outer Membrane of Gram-Negative Bacteria
Osborn, M., & Wu, H. C. (1980) · Annual Review of Microbiology · doi:10.1146/annurev.mi.34.100180.002101 · Cited by 280
Mutants of Escherichia coli That Are Resistant to Certain Beta-Lactam Compounds Lack the ompF Porin
Harder, K. J., Nikaido, H., & Matsuhashi, M. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.20.4.549 · Cited by 183
Cited by
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Campoli-Richards, D. M., Monk, J. P., Price, A., Benfield, P., Todd, P. A., & Ward, A. (1988) · Drugs · doi:10.2165/00003495-198835040-00003 · Cited by 749
Wolfson, J. S., & Hooper, D. C. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.4.581 · Cited by 698
Poole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance
Speer, B. S., Shoemaker, N. B., & Salyers, A. A. (1992) · Clinical Microbiology Reviews · doi:10.1128/cmr.5.4.387 · Cited by 517
Blaser, J., Stone, B. B., Groner, M. C., & Zinner, S. H. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1054 · Cited by 481
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon
Alekshun, M. N., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2067 · Cited by 470
Outer membrane barrier as a mechanism of antimicrobial resistance
Nikaido, H. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1831 · Cited by 462
Ciprofloxacin: An Updated Review of its Pharmacology, Therapeutic Efficacy and Tolerability
Davis, R., Markham, A., & Balfour, J. A. (1996) · Drugs · doi:10.2165/00003495-199651060-00010 · Cited by 389
Cohen, S. P., Hächler, H., & Levy, S. B. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.5.1484-1492.1993 · Cited by 388
Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 371
Antibiotic Resistance Caused by Gram‐Negative Multidrug Efflux Pumps
Nikaido, H. (1998) · Clinical Infectious Diseases · doi:10.1086/514920 · Cited by 348
Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
New Mechanisms of Bacterial Resistance to Antimicrobial Agents
Epstein, F. H., Jacoby, G. A., & Archer, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102283240906 · Cited by 312
Braoudaki, M., & Hilton, A. C. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.73-78.2004 · Cited by 273
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance
Kim, S., Lieberman, T. D., & Kishony, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409800111 · Cited by 264
Metadata
- Authors
- Sanders, C. C., Sanders, W. E., Goering, R. V., & Werner, V
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1984-12
- Volume
- 26
- Issue
- 6
- Pages
- 797-801
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2068188419
- Cited by
- 283
- References
- 17
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.